List view / Grid view
26 June 2015 | By Victoria White
The EC has approved Simponi (golimumab) for the treatment of adult patients with severe, active non-radiographic axial spondyloarthritis (nr-axial SpA)...
26 June 2015 | By Victoria White
The UK Court of Appeal has ruled in favour of Lilly in the Actavis v. Eli Lilly and Company Alimta vitamin regimen patent lawsuit...
25 June 2015 | By Victoria White
Plans to create a £10bn megafund that would make it easier for drug development will be discussed at a conference hosted by the Mayor of London’s Office...
25 June 2015 | By Victoria White
The patient enrollment for the Phase III CONCERTO trial of laquinimod in patients with relapsing-remitting multiple sclerosis (RRMS) has been finalised...
25 June 2015 | By Victoria White
The EC has granted marketing authorisation approval for perampanel for primary generalised tonic-clonic (PGTC) seizures in patients with epilepsy...
25 June 2015 | By Victoria White
The viscosupplementation market value will increase to a little under $2.64 billion by 2021, across the ten major markets, says GlobalData...
25 June 2015 | By
Results of four trials provide additional evidence supporting the safety and tolerability of hESC-derived retinal pigment epithelium...
25 June 2015 | By Victoria White
Futura Medical has received all of the regulatory approvals needed to begin its efficacy trial of erectile dysfunction treatment MED2002...
25 June 2015 | By Victoria White
The European Commission (EC) has granted Marketing Authorisation for Daiichi Sankyo’s Lixiana, an oral, once-daily selective factor Xa-inhibitor...
24 June 2015 | By Victoria White
Researchers have pinpointed a critical differentiator that separates the effects of bactericidal and bacteriostatic antibiotics: cellular respiration...
24 June 2015 | By Victoria White
Researchers who analysed more than 20,000 medical records concluded that erectile dysfunction drugs, such as Viagra, are not a cause of melanoma...
24 June 2015 | By Victoria White
Novo Nordisk announced the interim data from an extension trial of Novoeight at the International Society on Thrombosis and Haemostasis 2015 congress...
24 June 2015 | By Victoria White
TURQUOISE-III study results demonstrate 100% sustained virologic response in genotype 1b chronic HCV patients with compensated liver cirrhosis...
24 June 2015 | By Victoria White
A Phase 2/3 clinical study of ELND005 in agitation and aggression in patients with Alzheimer's disease (AD) did not meet its primary efficacy endpoint...
24 June 2015 | By Victoria White
EMA grants Orphan Drug designation to AveXis' gene transfer therapeutic currently in clinical development for the treatment of spinal muscular atrophy...
